Marketing Authorization Application License Renewal, MAA Submissions, PSUR
Freyr helps pharma manufacturers in filing Market Authorization Application (MAA) License renewal, PSUR Submissions as per HAs requirement for EU by Mutual Recognition Procedure (MRP), Decentralized Procedure (DCP) & Centralized Procedure (CP)
A marketing authorization (MA) granted by European Union (EU) competent authority is usually valid for 5 years. If the manufacturer willing to continue, marketing authorization holder (MAH) will have to renew the MA Application (MAA) License by filing renewal application to MAA in accordance with Article 24 of Directive 2001/83/EC and Article 14 (1-3) of Regulation (EC) No 726/2004. The renewal application shall be submitted to competent EU member state’s Health Authority (HA) by MAH at least 9 months before its expiry and failing to which, the validity of MA will lapse.
Once the MAA is renewed, it shall remain valid for lifetime, unless the competent authority of EU member state decides to have one more renewal based on pharmacovigilance, including exposure of an insufficient number of patients to the medicinal product and to process with one additional 5-year renewal. Even if the marketing authorization is valid for lifetime, MAH has to submit a Periodic Safety Update Report (PSUR) / a Periodic Benefit Risk Evaluation Report (PBRER) for every 3 years to HA.
The authority can be approached for MAA License renewal in one of the following ways depending upon the requirement of the case:
A marketing authorization (MA) granted by European Union (EU) competent authority is usually valid for 5 years. If the manufacturer willing to continue, marketing authorization holder (MAH) will have to renew the MA Application (MAA) License by filing renewal application to MAA in accordance with Article 24 of Directive 2001/83/EC and Article 14 (1-3) of Regulation (EC) No 726/2004. The renewal application shall be submitted to competent EU member state’s Health Authority (HA) by MAH at least 9 months before its expiry and failing to which, the validity of MA will lapse.
Once the MAA is renewed, it shall remain valid for lifetime, unless the competent authority of EU member state decides to have one more renewal based on pharmacovigilance, including exposure of an insufficient number of patients to the medicinal product and to process with one additional 5-year renewal. Even if the marketing authorization is valid for lifetime, MAH has to submit a Periodic Safety Update Report (PSUR) / a Periodic Benefit Risk Evaluation Report (PBRER) for every 3 years to HA.
The authority can be approached for MAA License renewal in one of the following ways depending upon the requirement of the case:
- Renewal through Centralized Procedure (CP)
- Renewal through Mutual Recognition Procedure (MRP) and Decentralized Procedure (DCP)
Comments
Post a Comment